Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, 395 W. 12Th Ave., Suite 670, Columbus, OH, USA.
Department of Surgery, University of Verona, Verona, Italy.
World J Surg. 2023 Jul;47(7):1792-1800. doi: 10.1007/s00268-023-06974-x. Epub 2023 Apr 3.
The prognostic impact of major postoperative complications (POCs) for intrahepatic cholangiocarcinoma (ICC) remains ill-defined. We sought to analyze the relationship between POCs and outcomes relative to lymph node metastases (LNM) and tumor burden score (TBS).
Patients who underwent resection of ICC between 1990-2020 were included from an international database. POCs were defined according to Clavien-Dindo classification ≥ 3. The prognostic impact of POCs was estimated relative to TBS categories (i.e., high and low) and lymph node status (i.e., N0 or N1).
Among 553 patients who underwent curative-intent resection for ICC, 128 (23.1%) individuals experienced POCs. Low TBS/N0 patients who experienced POCs presented with a higher risk of recurrence and death (3-year cumulative recurrence rate; POCs: 74.8% vs. no POCs: 43.5%, p = 0.006; 5-year overall survival [OS], POCs 37.8% vs. no POCs 65.8%, p = 0.003), while POCs were not associated with worse outcomes among high TBS and/or N1 patients. The Cox regression analysis confirmed that POCs were significant predictors of poor outcomes in low TBS/N0 patients (OS, hazard ratio [HR] 2.91, 95%CI 1.45-5.82, p = 0.003; recurrence free survival [RFS], HR 2.42, 95%CI 1.28-4.56, p = 0.007). Among low TBS/N0 patients, POCs were associated with early recurrence (within 2 years) (Odds ratio [OR] 2.79 95%CI 1.13-6.93, p = 0.03) and extrahepatic recurrence (OR 3.13, 95%CI 1.14-8.54, p = 0.03), in contrast to patients with high TBS and/or nodal disease.
POCs were independent, negative prognostic determinants for both OS and RFS among low TBS/N0 patients. Perioperative strategies that minimize the risk of POCs are critical to improving prognosis, especially among patients harboring favorable clinicopathologic features.
主要术后并发症(POC)对肝内胆管癌(ICC)的预后影响仍不明确。我们旨在分析 POC 与淋巴结转移(LNM)和肿瘤负担评分(TBS)之间的关系。
我们从一个国际数据库中纳入了 1990 年至 2020 年期间接受 ICC 切除术的患者。POC 根据 Clavien-Dindo 分类定义为≥3 级。我们根据 TBS 类别(高和低)和淋巴结状态(N0 或 N1)来评估 POC 的预后影响。
在 553 例接受 ICC 根治性切除术的患者中,128 例(23.1%)发生 POC。低 TBS/N0 患者发生 POC 后复发和死亡的风险更高(3 年累积复发率;POC:74.8% vs. 无 POC:43.5%,p=0.006;5 年总生存率 [OS],POC:37.8% vs. 无 POC:65.8%,p=0.003),而在高 TBS 和/或 N1 患者中,POC 与较差的预后无关。Cox 回归分析证实,POC 是低 TBS/N0 患者不良预后的显著预测因素(OS,风险比 [HR] 2.91,95%CI 1.45-5.82,p=0.003;无复发生存率 [RFS],HR 2.42,95%CI 1.28-4.56,p=0.007)。在低 TBS/N0 患者中,POC 与早期复发(2 年内)(比值比 [OR] 2.79,95%CI 1.13-6.93,p=0.03)和肝外复发(OR 3.13,95%CI 1.14-8.54,p=0.03)相关,而与高 TBS 和/或淋巴结疾病患者不同。
POC 是低 TBS/N0 患者 OS 和 RFS 的独立、负面预后决定因素。降低 POC 风险的围手术期策略对于改善预后至关重要,尤其是对于具有有利临床病理特征的患者。